Daniel J. Brennan, EVP and CFO at BOSTON SCIENTIFIC CORP (BSX), sold 24,590 shares at $89.86 ($2.2M) on 2025-01-03, disclosed to the SEC on 2025-01-03.
Scheduled sale ($2.2M) by EVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.32 | 5,212 | $466K | 21.1% |
| 2 | $89.86 | 9,689 | $871K | 39.5% |
| 3 | $89.86 | 9,689 | $871K | 39.5% |
| Total | $89.75 avg | 24,590 | $2.2M | 100% |
| Filing → |
| BSX | SELL | 2024-05-23 | $16.9M | — | Filing → |
| BSX | SELL | 2024-02-20 | $1.8M | — | Filing → |
| BSX | SELL | 2023-03-02 | $8.5M | — | Filing → |